Advertisement

Endoscopic Management of Bladder Tumors in Children

  • Mohamed Abouheba
  • Sameh ShehataEmail author
Chapter

Abstract

Urinary bladder tumors are not common in children and adolescents. They are either urothelial or non-urothelial (Fig. 65.1). The commonest is rhabdomyosarcoma (RMS) of the bladder or prostate/vagina followed by papillary urothelial tumors (Table 65.1) [1]. RMS, being the commonest childhood soft tissue sarcoma, ranks third commonest pediatric solid tumor (5–15%) [2, 3]. A recent analysis of 57 reports of pediatric urothelial bladder tumors which included 127 cases reported patients younger than 20 years old, of which only 21 patients (16.5%) were below 10 years old [4]. Both tumor categories exhibit a 3–9:1 male-to-female preponderance [5].

References

  1. 1.
    Berrettini A, Castagnetti M, Salerno A, Nappo SG, Manzoni G, Rigamonti W, Caione P. Bladder urothelial neoplasms in pediatric age: experience at three tertiary centers. J Pediatr Urol. 2015;11(1):26.CrossRefGoogle Scholar
  2. 2.
    Lerena J, Krauel L, Garcia-Aparicio L, et al. Transitional cell carcinoma of the bladder in children and adolescents: six-case series and review of the literature. J Pediatr Urol. 2010;21:75–8.Google Scholar
  3. 3.
    Shelmerdine SC, Lorenzo AJ, Gupta AA, Chavhan GB. Pearls and pitfalls in diagnosing pediatric urinary bladder masses. Radiographics. 2017;37:1872–91.CrossRefGoogle Scholar
  4. 4.
    Umlauf VN, Coerdt W, Leuschner I, et al. How to name papillary tumors of the bladder in children: transitional cell carcinoma or papillary urothelial neoplasm of low malignant potential? Urology. 2015;86:379–83.CrossRefGoogle Scholar
  5. 5.
    Rodeberg DA, Anderson JR, Arndt CA, et al. Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children’s Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee. Int J Cancer. 2011;128:1232–9.CrossRefGoogle Scholar
  6. 6.
    Williamson SR, Lopez-Beltran A, MacLennan GT, Montironi R, Cheng L. Unique clinicopathologic and molecular characteristics of urinary bladder tumors in children and young adults. Urol Oncol. 2013;31(4):414–26.CrossRefGoogle Scholar
  7. 7.
    Spiegelberg C, Giedl J, Gaisa NT, Rogler A, Riener MO, Filbeck T, Burger M, Ruemmele P, Hartmann A, Stoehr R. Frequency of activating mutations in FGFR2 exon 7 in bladder tumors from patients with early-onset and regular-onset disease. Int J Clin Exp Pathol. 2014;7(4):1708–13.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Kojima S, Yagi M, Asagiri K, Fukahori S, Tanaka Y, Ishii S, Saikusa N, Koga Y, Yoshida M, Masui D, Komatsuzaki N, Nakagawa S, Ozono S, Tanikawa K. Infantile neuroblastoma of the urinary bladder detected by hematuria. Pediatr Surg Int. 2013;29(7):753–7.CrossRefGoogle Scholar
  9. 9.
    Huppmann AR, Pawel BR. Polyps and masses of the pediatric urinary bladder: a 21-year pathology review. Pediatr Dev Pathol. 2011;14(6):438–44.CrossRefGoogle Scholar
  10. 10.
    Ray B, Grabstald H, Exelby PR, Whitmore WF Jr. Bladder tumors in children. Urology. 1973;2(4):426–35.CrossRefGoogle Scholar
  11. 11.
    Klochko PI, Kononenko NG. Diagnosis of bladder tumors in children. Urol Nefrol (Mosk). 1987;(5):58–60.Google Scholar
  12. 12.
    Hartman C, Williamson AK, Friedman AA, Palmer LS, Fine RG. Bladder ganglioneuroma in a 5-year-old girl presenting with a urinary tract infection and hematuria: case report and review of the literature. Urology. 2015;85(2):467–9.CrossRefGoogle Scholar
  13. 13.
    Stein R, Frees S, Schröder A, Russo A, Gutjahr P, Faber J, Thüroff JW. Radical surgery and different types of urinary diversion in patients with rhabdomyosarcoma of bladder or prostate—a single institution experience. J Pediatr Urol. 2013;9(6 Pt A):932–9.CrossRefGoogle Scholar
  14. 14.
    Chen H, Niu ZB, Yang Y. Bladder leiomyoma in a 6-year-old boy. Urology. 2012;79(2):434–6.CrossRefGoogle Scholar
  15. 15.
    Yan C, Kim YW, Ha YS, Kim IY, Kim YJ, Yun SJ, Moon SK, Bae SC, Kim WJ. RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer. J Surg Oncol. 2012;105(4):425–30.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Pediatric Surgery Division, Children’s Hospital, Alexandria UniversityAlexandriaEgypt

Personalised recommendations